Top 3 Emerging Trends Impacting the Global Intraosseous Infusion Devices Market from 2017-2021: Technavio

Technavio has published a new report on the global intraosseous infusion devices market from 2017-2021. (Graphic: Business Wire)

???pagination.previous??? ???pagination.next???

LONDON--()--Technavio’s latest report on the global intraosseous infusion devices market provides an analysis of the most important trends expected to impact the market outlook from 2017-2021. Technavio defines an emerging trend as a factor that has the potential to significantly impact the market and contribute to its growth or decline.

The research study by Technavio on the global intraosseous infusion devices market for 2017-2021 provides a detailed industry analysis based on product type (automatic and manual), end-user (hospitals, pre-hospital emergency care, and military care), and geography (the Americas, EMEA, and APAC).

Intraosseous infusion devices are primarily used in medical emergencies to provide an easy and rapid flow of fluids, drugs, and medication through the bone marrow. The global intraosseous infusion devices market size is projected to grow to USD 439.8 million by 2021, at a CAGR of close to 5% over the forecast period.

Request a sample report: http://www.technavio.com/request-a-sample?report=56886

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

The top three emerging trends driving the global intraosseous infusion devices market according to Technavio healthcare and life sciences research analysts are:

  • Growing use of intraosseous infusion devices in pediatric cases
  • Growing adoption of automatic intraosseous access devices
  • Use of product bundling strategy

Growing use of intraosseous infusion devices in pediatric cases

Intraosseous infusion devices have become very safe and efficient while rapidly providing passage for medication and other fluids to the patient. These advances have paved the way for their use in pediatrics as well,” says Barath Palada, a lead analyst at Technavio for orthopedics and medical devices research.

To meet the demand from the pediatric segment, vendors are providing the EZ-IO needle in different gauges suitable for the younger patients. Both automatic and manual intraosseous needles are used by this sector, making way for quick intravascular infusion access.

Growing adoption of automatic intraosseous access devices

Automatic intraosseous needles are becoming increasingly popular due to the innovative features that provide appropriate access, space, depth, and high maneuverability. Also, automatic intraosseous access devices are user-friendly, compact, safe, reliable, provide high flow rates, and suitable for use in extreme conditions. For instance, BIG - the world's first automatic intraosseous infusion device, can establish access in less than 60 seconds. These features and characteristics of automatic intraosseous infusion devices will boost the market growth.

Use of product bundling strategy

Various vendors in the intraosseous infusion devices market are adopting the product bundling strategy to overcome acquisition related costs, increase profits and product awareness, and encourage their increased use in healthcare centers,” says Barath.

Products such as infusion needles, hypodermic needles, surgical sets, and trays containing infusion devices are bundled together and sold at a lower price point to attract more customers. This strategy is gaining popularity in the healthcare sector since it allows vendors to sell multiple products together and helps reduce product compatibility complications, thereby increasing product penetration and driving market growth.

Browse Related Reports:

Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like medical imaging, oncology, and vaccines. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, resellers, and end-users.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com

Release Summary

Technavio’s latest report on the global intraosseous infusion devices market provides an analysis of the most important trends expected to impact the market outlook from 2017-2021.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com